Blood transfusion (NG24)Product type:GuidanceProgramme:NICE guidelineLast updated: 26 February 2026Published: 18 November 2015
Letermovir for preventing cytomegalovirus infection after a kidney transplant (terminated appraisal) (TA1082)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 July 2025
Maribavir for treating refractory cytomegalovirus infection after transplant (TA860)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 18 January 2023
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease (TA809)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 July 2022
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant (HTG580)Product type:GuidanceProgramme:HealthTech guidancePublished: 26 May 2021
Ex-situ machine perfusion for extracorporeal preservation of livers for transplantation (HTG496)Product type:GuidanceProgramme:HealthTech guidancePublished: 16 January 2019
Robot-assisted kidney transplant (HTG468)Product type:GuidanceProgramme:HealthTech guidancePublished: 25 April 2018
Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure (HTG459)Product type:GuidanceProgramme:HealthTech guidancePublished: 20 December 2017
Immunosuppressive therapy for kidney transplant in adults (TA481)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 11 October 2017
Immunosuppressive therapy for kidney transplant in children and young people (TA482)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 11 October 2017
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation (CG135)Product type:GuidanceProgramme:Clinical guidelineLast updated: 21 December 2016Published: 12 December 2011
Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death (HTG404)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 February 2016
Living-donor liver transplantation (HTG390)Product type:GuidanceProgramme:HealthTech guidancePublished: 25 November 2015
Everolimus for preventing organ rejection in liver transplantation (TA348)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Hand allotransplantation (HTG254)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 March 2011
Corneal endothelial transplantation (HTG195)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 June 2009
Machine perfusion systems and cold static storage of kidneys from deceased donors (TA165)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 January 2009
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (HTG175)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 September 2008
Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery (HTG115)Product type:GuidanceProgramme:HealthTech guidancePublished: 28 June 2006
Living-donor lung transplantation for end-stage lung disease (HTG111)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 May 2006
Laparoscopic live donor simple nephrectomy (HTG30)Product type:GuidanceProgramme:HealthTech guidancePublished: 27 May 2004
OrganOx metra for liver transplant (MIB275)Product type:AdviceProgramme:Medtech innovation briefingPublished: 14 September 2021
Hemosep for cell salvage (MIB103)Product type:AdviceProgramme:Medtech innovation briefingPublished: 3 May 2017
OCS Heart system for heart transplant (MIB86)Product type:AdviceProgramme:Medtech innovation briefingPublished: 29 November 2016
Blood transfusion (QS138)Product type:Quality standardLast updated: 26 February 2026Published: 15 December 2016
Ex-situ machine perfusion devices to preserve deceased donor livers for transplantationStatus:In development | In consultationProgramme:Health technology evaluationConsultation end date: 10 June 2026Expected publication date: 20 August 2026
Ex-situ machine perfusion devices for lung transplantsStatus:In developmentProgramme:Health technology evaluationExpected publication date: 21 October 2026
In-situ normothermic regional perfusion of the abdomen for livers donated after controlled circulatory deathStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 19 November 2026
Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
XVIVO hypothermic perfusion of the DCD heartStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Dermal allograft augmentation in proximal humerus fracture fixationStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC